The contract decision-making process was based on extensive member-driven criteria, including value, product line breadth, clinical acceptability, new product development, and service capabilities.
“We welcome the opportunity to provide Ossur’s innovative products and excellent service to the members of VHA, UHC and Provista,” said Mahesh Mansukhani, president of Ossur Americas. “Together, we will better meet our customers growing needs for value and quality,” he added.
Scott Crandall, senior director of Novation commented, “We are pleased to have the opportunity to offer this leading brand to the members. Based on a recent Novation study, we know that the weakened economy has hit hospitals particularly hard and they are being forced to make some tough decisions. The Ossur contract supports our goal of ensuring that members have access to the most innovative and highest quality medical products at the best value.”
